Efficacy and quality of life with once-daily sublingual immunotherapy with grasses plus olive pollen extract without updosing.

Abstract

Once-daily sublingual immunotherapy without updosing was well tolerated. The actively treated patients showed a significant reduction in symptom and medication scores and an improvement in their quality of life although there were no significant differences between the groups probably due to the low allergen season in which the study was evaluated.